Brand Logo

News & Events

CLEARINGHOUSE Q&A SESSIONS WITH FMCSA



FMCSA will host live informational webinars to help users understand the requirements of the Clearinghouse. The presentations will walk through Clearinghouse features and will include time for questions. Select the session most relevant to you and register using the links below. Because space is limited, we request that you register for only one session. A recording of the webinars will be available to all users at a later date.

Clearinghouse for Substance Abuse Professionals and Medical Review Officers

Join us on Thursday, December 5, 2019, 10:00-11:30 am ET

Register


Join us on Wednesday, January 22, 2020, 9:30-11:00 am ET

Register

Clearinghouse for Employers, Consortia/Third-Party Administrators, and CDL Drivers

Join us on Thursday, December 10, 2019, 11:00 am-12:30 pm ET

Register


Join us on Wednesday, January 23, 2020, 1:30-3:00 pm ET

Register

New Oral Fluid Guidelines from SAMHSA - What You Need to Know



Due to the release of the Substance Abuse and Mental Health Services Administration’s (SAMHSA’s) oral fluid mandatory guidelines for federal workplaces, the topic of the November 5th webinar has been adjusted to reflect this exciting change and to better help you understand its impact. Marijuana Today: What You Need to Know will be offered at a later date.

Join us on Tuesday, November 5th, 2019 2:00 pm EST.

Register Now

Drug & Alcohol Clearinghouse



Query plans will be available for purchase on the Clearinghouse website in fall 2019. FMCSA has released the query plan options for employers of CDL drivers. The query plan information is in the attached factsheet, it is also available for download on the Clearinghouse website.

What are Clearinghouse queries?
Beginning January 6, 2020, employers subject to the Clearinghouse final rule will be required to take certain actions in the Clearinghouse, such as querying the Clearinghouse for information on current and prospective employees to verify they are not prohibited from performing safety-sensitive functions due to an unresolved drug and alcohol program violation. Employers will be required to query the Clearinghouse as part of every pre-employment driver investigation, and at least annually for drivers they employ. All queries require driver consent.

Read More

Industry Sessions



Each of our sessions features an industry expert to present industry trends, news, regulatory updates, and informative employment screening procedures your company can take to build a safer workplace. DISA is working to offer HRCI, SHRM, and CC DAPP continuing education credits for sessions that qualify. As we get closer to the event, we'll send all registered attendees more information about earning these credits!

Join us on Thursday, October 24th, 2019

Read More & Register Now

Why you should turn on digital drug testing



From collection to lab testing, the five-part Custody and Control Form kicks off a drug test order and documents the chain of custody. However, utilizing paper comes with drawbacks. Fortunately, a more efficient solution is available to help streamline the entire drug testing process: electronic Custody and Control Forms, or eCCF.

In our upcoming webinar, Flip the switch: why you should turn on digital drug testing, Quest Diagnostics experts Denise Mullins, senior manager of technical support development, Ryan Osborn, technical product development manager, and Anthony Magazzolo, technical product development manager, will discuss the value of adopting digital solutions for workplace drug testing.

Join us on Wednesday, July 31 at 1:00 PM CT.

Register Now

Expanded Clearinghouse FAQs from FMCSA

FMCSA has enhanced the FAQs on the Clearinghouse website. Visit the new FAQs page to access more than 50 questions and answers. You can search or filter to find specific information.

Read the new FAQs

Back to basics webinar series | Part 2



Drug testing can be complicated and requires learning the fundamentals to execute a successful, drug-free workplace program. Regardless of whether you are new to drug testing or a seasoned veteran, it is important to understand the benefits of different specimen types and which drug test best fits the unique needs of your workforce.

In the second installment of our webinar series, Back to basics, we take a closer look at oral fluid drug testing and the power of an observed collection. Join Kimberly Samano, PhD, scientific director at Quest Diagnostics, as she shares her expertise about oral fluid testing and discusses its accuracy, versatility, and effectiveness in detecting drugs.

join us on Wednesday, March 20 at 1 PM CT.

Register now

Drug and Alcohol Testing MIS Data Collection Form

Employers subject to DOT or USCG drug and alcohol testing regulations must submit their annual drug and alcohol testing data as required by their respective DOT Agency or the USCG. The annual drug and alcohol testing data being submitted for a specific calendar year is to be submitted by March 15th of the following calendar year.

Example: If you are required to submit drug and alcohol testing data for the calendar year of 2018, then you must submit your data by March 15, 2019.

When submitting their drug and alcohol testing data, employers are to use the following Drug and Alcohol Testing MIS Data Collection Form and instructions.

READ MORE

FMCSA Streamlines Process Allowing Individuals with Properly Managed Diabetes to Operate Commercial Motor Vehicles

FMCSA revises its regulations to permit individuals with a stable insulin regimen and properly controlled insulin-treated diabetes mellitus (ITDM) to be qualified to operate commercial motor vehicles (CMVs) in interstate commerce. Previously, ITDM individuals were prohibited from driving CMVs in interstate commerce unless they obtained an exemption from FMCSA. This rule enables a certified medical examiner (ME) to grant an ITDM individual a Medical Examiner’s Certificate (MEC), MCSA-5876, for up to a maximum of 12 months. To do so, the treating clinician (TC), the healthcare professional who manages, and prescribes insulin for, the treatment of the individual’s diabetes, provides the Insulin-Treated Diabetes Mellitus Assessment Form (ITDM Assessment Form), MCSA-5870, to the certified ME indicating that the individual maintains a stable insulin regimen and proper control of his or her diabetes. The certified ME then determines that the individual meets FMCSA’s physical qualification standards and can operate CMVs in interstate commerce.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, Medical Programs Division, Federal Motor Carrier Safety Administration, 1200 New Jersey Avenue, SE., Washington, DC 20590 0001, by telephone at (202) 366-4001, or by email at fmcsamedical@dot.gov. If you have questions on viewing or submitting material to the docket, contact Docket Services, telephone (202) 366-9826.

READ MORE DETAILS (PDF)

Extension of Compliance Dates for Medical Examiner's Certification Integration

FMCSA amends its regulations to delay the compliance date from June 22, 2018, to June 22, 2021, for several provisions of its April 23, 2015 Medical Examiner's Certification Integration final rule. This action is being taken to provide FMCSA additional time to complete certain information technology (IT) system development tasks for its National Registry of Certified Medical Examiners (National Registry) and provide the State Driver's Licensing Agencies (SDLAs) sufficient time to make the necessary IT programming changes after upgrades to the National Registry.

DOT is committed to ensuring that information is available in appropriate alternative formats to meet the requirements of persons who have a disability. If you require an alternative version of files provided on this page, please contact fmcsamedical@dot.gov.

READ MORE DETAILS (PDF)
  • CONTACT

  • 1.844.C1.FIRST (844.213.4778)
  • Fax: 732.443.3620
  • info@complyfirst.com
  • Careers